Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 7 Gastrointestinal 4 Head & Neck 2 Tumor-Agnostic 1 Other solid neoplasm 1 Gynecologic 1 Genitourinary 1 Dermatologic 1 Breast 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 264 Carboplatin 246 Cisplatin 153 Bevacizumab 104 Gemcitabine 78 Topotecan 77 liposomal doxorubicin 67 pembrolizumab 60 Docetaxel 56 Cyclophosphamide 50 Taxes 48 Radiotherapy 44 olaparib 43 Surveys and Questionnaires 43 Doxorubicin 43 Filgrastim 42 Brachytherapy 37 Drug Therapy 31 niraparib 28 Blood Specimen Collection 28 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 26 human papillomavirus vaccine, L1 type 16, 18 24 Peripheral Blood Stem Cell Transplantation 23 atezolizumab 22 Oxaliplatin 22 Pemetrexed 21 Nivolumab 21 Hyperthermic Intraperitoneal Chemotherapy 21 Etoposide 21 Immunoglobulin G 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Tiragolumab × Gynecologic × Clear all

NCT04300647 2026-03-12

SKYSCRAPER-04

Hoffmann-La Roche

Phase 2 Completed

172 enrolled 27 charts

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡